Q3 2019 Holdings
Filed 2019-11-13 | 14 holdings | $324.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $110.0K | 6,553,116 | 34.0% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $70.7K | 5,103,455 | 21.8% |
| Morphic Holding | Common Stock | 61775R105 | $53.8K | 2,969,582 | 16.6% |
| Translate Bio | Common Stock | 89374L104 | $24.2K | 2,437,603 | 7.5% |
| Immunic(IMUX) | Common Stock | 4525EP101 | $13.7K | 1,371,494 | 4.2% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $11.2K | 2,600,410 | 3.5% |
| ObsEva | Common Stock | H5861P103 | $8.3K | 999,364 | 2.6% |
| Prevail Therapeutics | Common Stock | 74140Y101 | $8.2K | 668,908 | 2.5% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $5.8K | 1,709,848 | 1.8% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $5.7K | 1,263,408 | 1.8% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $4.8K | 130,646 | 1.5% |
| Cidara Therapeutics | Common Stock | 171757107 | $3.3K | 1,640,514 | 1.0% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $2.6K | 750,741 | 0.8% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $1.8K | 529,965 | 0.5% |